Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. Covidien absorbs $2 billion in shares
After posting a stellar quarter with a 47 percent bump in earnings, Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program.
2. The stent wars continue: Abbott versus Boston Scientific
In the latest battle, Abbott Laboratories’ (NYSE:ABT) Xience V drug-eluting stent beat out DES market leader Boston Scientific Corp.’s (NYSE:BSX) Taxus in nondiabetic patients.
1. SNN whistleblower demands sales docs
A former Smith & Nephew (NYSE:SNN) executive wants a Tennessee federal court to force the company to cough up documents detailing its sales to the U.S. government.